Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Institut Gustave-Roussy

The Institute Gustave-Roussy is a non-profit private institution, exclusively devoted to oncology.It is part of the French public hospital system.
State-approved, it is authorised to receive donations and legacies (Decree of October 1st 1945).


Contact Details:
39 rue Camille
Desmoulins
Villejuif Cedex
94805
France
Tel:00 33 1 42 11 42 11
Fax:00 33 1 42 11 53
Email:roussy@igr.fr
WWW:

www.igr.fr/




Recent Publications by Institut Gustave-Roussy:

Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells.
Doxorubicin (DOX), a member of the anthracycline group, is a widely used...
21st November, 2009
Biophysics Department, UFRGS, Porto Alegre, Brazil; Laboratory of Genetic DNA Repair (Amst). 2009 Nov 16.
DOI Direct Link
Relation of risk of contralateral breast cancer to the interval since the first primary tumour.
Background:There is no consensus on how to separate contralateral breast...
19th November, 2009
[1] Institut National de la Sante et de la Recherche Medicale (INSERM), Br J Cancer. 2009 Nov 17.
DOI Direct Link
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer.
PURPOSE: Antiproliferative and antiosteoclastic activity from preclinical...
19th November, 2009
Authors' Affiliations: University of Washington, Seattle, Washington; Clin Cancer Res. 2009 Nov 17.
DOI Direct Link
[New drugs and targeted therapeutic agents in ovarian cancer.]
Ovarian cancers are the leading cause of death from gynaecological...
19th November, 2009
Institut Gustave-Roussy, Comite de gynecologie, Villejuif, France. Bull Cancer. 2009 Nov 18.
DOI Direct Link
Birth weight, body silhouette over the life course and incident diabetes in 91,453 middle-aged women from the French E3N cohort.
Objective- Obesity and increases in body weight in adults are considered...
18th November, 2009
INSERM, ERI 20, EA 4045, Institut Gustave-Roussy, F-94805, Villejuif, Diabetes Care. 2009 Nov 16.
DOI Direct Link

View more Institut Gustave-Roussy research publications.

Press Releases on Institut Gustave-Roussy:

BioPortfolio Logo
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer 23rd October, 2009 Onyx Pharmaceuticals, Inc.
WAYNE, N.J. and EMERYVILLE, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the companies have begun
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer 10th July, 2009 Ipsogen SA
MARSEILLE, France, July 10 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext: ALIPS) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 4th May, 2009 Ipsogen SA
MARSEILLE, France, May 4 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, the manufacturing and the
ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform 16th March, 2009 ExonHit Therapeutics SA
PARIS, March 16 /PRNewswire-FirstCall/ -- ExonHit Therapeutics (Alternext: ALEHT) today reported the publication in Lancet Oncology of a study conducted by Institut Gustave Roussy, which describes
Advances in Renal Cancer Journalists' Award 25th February, 2009
LEVERKUSEN, Germany, February 25 /PRNewswire/ -- Bayer HealthCare and the Association of German Medical Journalists (VDMJ) have jointly announced the 2009 Advances in Renal Cancer Journalists'

BioNews Results for Institut Gustave-Roussy:

Trastuzumab for Patients With Axillary-Node-Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial [Breas
Journal of Clinical Oncology:  Nov 19 2009 6:31AM Matching: institut gustave roussy
Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retr
Journal of Clinical Oncology:  Nov 19 2009 6:35AM Matching: institut gustave roussy
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Mul
Journal of Clinical Oncology:  Nov 19 2009 6:36AM Matching: institut gustave roussy
Infantile Fibrosarcoma: Management Based on the European Experience [Pediatric Oncology]
Journal of Clinical Oncology:  Nov 19 2009 6:30AM Matching: institut gustave roussy
Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 20
Journal of Clinical Oncology:  Nov 19 2009 6:35AM Matching: institut gustave roussy
Promote your company here: BioNewsCast - Press Release Distribution

View more Institut Gustave-Roussy news.

Institut Gustave-Roussy Clinical Trials:

Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents

Institut Gustave-Roussy Patents:

US Patent No.Title
7476496 Method for preparing an extracellular matrix and its use for tumor cell culture
6410509 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 1069 individuals from Institut Gustave-Roussy using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1248 times since April 2007, the link to the organisation's website has been followed 258 times

Recent Search Terms used to find this page: gustave roussy hospital contact mail | clinic gustave roussy | clinic gustave roussy | clinic gustave roussy | clinic gustave roussy | clinica gustave roussy | institut gustave roussy cancer institute | institut gustave roussy cancer institute | Institut Gustave-Roussy | clinica Goustave roussi | .

Search for more companies in Desmoulins

Search for more companies in Villejuif Cedex



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Institut Gustave-Roussy

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.